Our Research

Research

At Houston Methodist, fostering innovations with the potential for clinical application is at the very heart of what we do. Our interdisciplinary teams of clinicians and researchers are committed to streamlining the process of translating discoveries into treatments and cures for our patients. 


Learn more about how we are delivering on our commitment to leading medicine from the earliest phase of discovery in a lab to the testing new drugs or therapies in clinical trials.


$9 MILLION FEDERAL GRANT TO STUDY PHYSICS OF CANCER IMMUNOTHERAPY

Houston Methodist received $9 million from the National Cancer Institute to establish a center focused on the physics of cancer immunotherapy. Mauro Ferrari, PhD, president and CEO of the Houston Methodist Research Institute, is leading this effort. Learn more.

Software For Reliably Interpreting Mammograms

Houston Methodist researchers led by Stephen T. Wong, PhD, PE, and Jenny C. Chang, MD, have developed an artificial intelligence software that accurately interprets mammograms for predicting breast cancer risk. Learn more. 

DOD AWARDS $4 MILLION TO COMBAT LETHAL BREAST CANCER

The DoD has awarded Rongfu Wang, PhD, and Jenny C. Chang, MD, nearly $4 million to develop a personalized immunotherapy approach to combat triple negative breast cancer. Learn more. 

THE BRICKER AWARD FOR SCIENCE WRITING IN MEDICINE
Amy Maxmen

Amy Maxmen, PhD, an award-winning freelance science journalist, is the very first recipient of the award and delivered the inaugural Bricker award lecture at the Houston Methodist Research Institute. Learn more.